Nio stock price prediction 2025: a 70% surge is possible
Nio stock price has had a rough year as its business faces substantial challenges, including elevated competition and losses. It was trading at $4.55 on Monday, meaning that it has…
Stock
1295 posts
Analyst sees HDFC Bank shares racing 18%: here’s why
HDFC Bank’s share price has had a volatile time in 2024. After a rough start to the year, the stock has made some recovery in the second half of the…
Expensive Asana stock price could surge by 195% in 2025
Asana stock price has suffered a harsh reversal in the past few days as investors fade the December 5 earnings surge. ASAN shares retreated to $21.65, down by over 22%…
Sprout Social stock is down 77% from ATH: time to buy the dip?
Sprout Social stock price has remained under pressure this year as the company’s growth trajectory slowed. SPT was trading at $32.45, down by over 77.5% from its all-time high, bringing…
As the ZipRecruiter stock price implodes, will it rebound in 2025?
ZipRecruiter (ZIP) stock price has imploded and crashed to a record low as concerns about its growth in a difficult job market continue. It has slipped to an all-time low…
Coursera stock price analysis: will this edtech giant rebound?
Coursera stock price has crashed to a near-record low as the company’s business growth decelerates amid an uptick in AI use. COUR was trading at $8.31, a few points above…
Will the falling Hims & Hers stock price recover in 2025?
Hims & Hers stock price has greatly performed this year as it continued to disrupt the healthcare industry. HIMS has jumped by almost 200% this year, while other companies in…
Novo Nordisk stock just tanked 25%: here’s what happened
Novo Nordisk A/S (CPH: NOVO-B) is being punished this morning after posting a disappointing update related to CagriSema. The pharmaceutical behemoth said its experimental weight-loss treatment helped patients lower their…
Humacyte stock may fail to sustain today’s gains: find out more
Shares of Humacyte Inc (NASDAQ: HUMA) nearly doubled on Friday after receiving full approval for its flagship SYMVESS product from the US Food and Drug Administration (FDA). Regulatory approval for…